Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain

Details for Australian Patent Application No. 2004246763 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Geisslinger, Gerd; Scholich, Klaus; Michaelis, Martin

Agent Watermark

Pub. Number AU-B-2004246763

PCT Pub. Number WO2004/110421

Priority 03012864.9 06.06.03 EP

Filing date 21 May 2004

Wipo publication date 23 December 2004

Acceptance publication date 28 May 2009

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/110421 Priority application(s): WO2004/110421

28 May 2009 Application Accepted

  Published as AU-B-2004246763

24 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004246765-Use of isoindolinone derivatives as insecticides

2004246760-Device for dynamically stabilizing bones or bone fragments, especially thoracic vertebral bodies